Virtu Financial’s Vaccinex, Inc. Common Stock VCNX Stock Holding History

Virtu Financial’s Portfolio VCNX Stock Details VCNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-495	Closed	-$42K	–	2194
2023 Q1	$42K	Buy	+495	New	+$54.4K	﹤0.01%	1128
2022 Q4	–	Sell	-49	Closed	-$5K	–	2265
2022 Q3	$5K	Sell	49 -3	-6%	-$589	﹤0.01%	1585
2022 Q2	$12K	Buy	+52	New	+$13.3K	﹤0.01%	1411
2021 Q3	–	Sell	-181	Closed	-$106K	–	2072
2021 Q2	$106K	Buy	181 +92	+103%	+$48.6K	0.01%	1191
2021 Q1	$56K	Buy	+89	New	+$57.2K	﹤0.01%	1419
2020 Q4	–	Sell	-125	Closed	-$47K	–	1872
2020 Q3	$47K	Buy	+125	New	+$136K	0.01%	832

Other funds holding VCNX

ACM

AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

WVP

Worth Venture Partners Fort Lee, New Jersey $44.3M AUM 34.55% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return

Virtu Financial's VCNX Position: Q2 2023 in Review

Virtu Financial sold out of Vaccinex, Inc. Common Stock (VCNX) in Q2 2023, closing a stake of 495 shares — an estimated $42K sold.

Virtu Financial first reported a position in VCNX in Q3 2020 and held it in 6 quarters. The position peaked at $106K in Q2 2021. 22 funds tracked by Wall St. Rank hold VCNX as of Q2 2023.

Virtu Financial reported no remaining Vaccinex, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Virtu Financial sold 495 Vaccinex, Inc. Common Stock shares in Q2 2023, an estimated $42K.
Virtu Financial first reported a position in Vaccinex, Inc. Common Stock in Q3 2020 and held it in 6 quarters.
Virtu Financial's Vaccinex, Inc. Common Stock position peaked at $106K in Q2 2021.
22 funds tracked by Wall St. Rank held Vaccinex, Inc. Common Stock as of Q2 2023.

Based on Virtu Financial's 13F filing for Q2 2023, filed 27 Jul 2023.